Detalhe da pesquisa
1.
Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib.
Blood
; 132(21): 2260-2272, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213872
2.
Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitors.
Bioorg Med Chem
; 27(5): 692-699, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30661740
3.
Cleavable Crosslinkers as Tissue Fixation Reagents for Proteomic Analysis.
Chembiochem
; 19(7): 736-743, 2018 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29356267
4.
Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study.
Org Biomol Chem
; 13(18): 5147-57, 2015 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849561
5.
Bioorthogonal chemistry: applications in activity-based protein profiling.
Acc Chem Res
; 44(9): 718-29, 2011 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21797256
6.
Photo-crosslinking of clinically relevant kinases using H89-derived photo-affinity probes.
Mol Biosyst
; 12(6): 1809-17, 2016 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27138522
7.
The novel ß2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells.
Cancer Chemother Pharmacol
; 76(2): 383-96, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26099967
8.
Integrating chemical and genetic silencing strategies to identify host kinase-phosphatase inhibitor networks that control bacterial infection.
ACS Chem Biol
; 9(2): 414-22, 2014 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24274083
9.
Incorporation of fluorinated phenylalanine generates highly specific inhibitor of proteasome's chymotrypsin-like sites.
J Med Chem
; 53(5): 2319-23, 2010 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20131905
10.
Changes in Fitness Components After a Four-Week Bicycle Tour.
Phys Sportsmed
; 10(5): 78-84, 1982 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278185